SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0000950137-05-012981
Filing Date
2005-10-27
Accepted
2005-10-27 16:41:05
Documents
4
Period of Report
2005-12-02
Effectiveness Date
2005-10-27

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE NOTICE AND PROXY STATEMENT a13487ddef14a.htm DEF 14A 1433358
2 GRAPHIC a13487da1348700.gif GRAPHIC 825
3 GRAPHIC a13487da1348701.gif GRAPHIC 2077
4 GRAPHIC a13487da1348702.gif GRAPHIC 9242
  Complete submission text file 0000950137-05-012981.txt   1451994
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-24274 | Film No.: 051160474
SIC: 2836 Biological Products, (No Diagnostic Substances)